These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. ⁸²Rb PET/CT: entering a new area of myocardial perfusion imaging? Valenta I; Schindler TH Eur J Nucl Med Mol Imaging; 2012 Aug; 39(8):1231-2. PubMed ID: 22652982 [No Abstract] [Full Text] [Related]
24. Evaluating the prognostic value of positron-emission tomography myocardial perfusion imaging using automated software to calculate perfusion defect size. Williams BA; Dorn JM; LaMonte MJ; Donahue RP; Trevisan M; Leonard DA; Greene RS; Merhige ME Clin Cardiol; 2012 Nov; 35(11):E14-21. PubMed ID: 22961671 [TBL] [Abstract][Full Text] [Related]
33. What is the prognostic value of myocardial perfusion imaging using rubidium-82 positron emission tomography? Yoshinaga K; Chow BJ; Williams K; Chen L; deKemp RA; Garrard L; Lok-Tin Szeto A; Aung M; Davies RA; Ruddy TD; Beanlands RS J Am Coll Cardiol; 2006 Sep; 48(5):1029-39. PubMed ID: 16949498 [TBL] [Abstract][Full Text] [Related]
34. Does quantification of myocardial flow reserve using rubidium-82 positron emission tomography facilitate detection of multivessel coronary artery disease? Ziadi MC; Dekemp RA; Williams K; Guo A; Renaud JM; Chow BJ; Klein R; Ruddy TD; Aung M; Garrard L; Beanlands RS J Nucl Cardiol; 2012 Aug; 19(4):670-80. PubMed ID: 22415819 [TBL] [Abstract][Full Text] [Related]
35. Will the new advantages provided by PET in myocardial perfusion imaging help nuclear cardiology survive the test of time against conventional radiological techniques? Caobelli F; Farina D; Pizzocaro C; Guerra UP Eur J Nucl Med Mol Imaging; 2012 Dec; 39(12):1970-2. PubMed ID: 22926711 [No Abstract] [Full Text] [Related]
36. Quantitative relationship between coronary artery calcium and myocardial blood flow by hybrid rubidium-82 PET/CT imaging in patients with suspected coronary artery disease. Assante R; Zampella E; Arumugam P; Acampa W; Imbriaco M; Tout D; Petretta M; Tonge C; Cuocolo A J Nucl Cardiol; 2017 Apr; 24(2):494-501. PubMed ID: 26780529 [TBL] [Abstract][Full Text] [Related]
37. Assessment of motion correction in dynamic rubidium-82 cardiac PET with and without frame-by-frame adjustment of attenuation maps for calculation of myocardial blood flow. Armstrong IS; Memmott MJ; Saint KJ; Saillant A; Hayden C; Arumugam P J Nucl Cardiol; 2021 Aug; 28(4):1334-1346. PubMed ID: 31388967 [TBL] [Abstract][Full Text] [Related]
38. Patient-tailored risk assessment of obstructive coronary artery disease using Rubidium-82 PET-based myocardial flow quantification with visual interpretation. Koenders SS; van Dalen JA; Jager PL; Mouden M; Slump CH; van Dijk JD J Nucl Cardiol; 2023 Oct; 30(5):1890-1896. PubMed ID: 37076608 [TBL] [Abstract][Full Text] [Related]
39. Predicting outcomes in heart transplantation: PET project or actionable data. Givertz MM Circ Cardiovasc Imaging; 2014 Nov; 7(6):857-9. PubMed ID: 25406196 [No Abstract] [Full Text] [Related]
40. Prognostic value of vasodilator response using rubidium-82 positron emission tomography myocardial perfusion imaging in patients with coronary artery disease. Arasaratnam P; Sadreddini M; Yam Y; Kansal V; Dorbala S; Di Carli MF; Beanlands RS; Merhige ME; Williams BA; Veledar E; Min JK; Chen L; Ruddy TD; Germano G; Berman DS; Shaw LJ; Chow BJW Eur J Nucl Med Mol Imaging; 2018 Apr; 45(4):538-548. PubMed ID: 29177706 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]